A nutritional supplement formulator in California spent three months trying to understand why a high-calcium bone health product was showing variable bioavailability results in a clinical pilot. The formula had not changed. The raw material supplier had not changed. The calcium source was the same on every purchase order. It took an outside consultant — a former regulatory chemist from a major pharmaceutical firm — to ask the question that cracked it: what exactly is your calcium source, and have you verified the mineralogical form batch by batch? The calcium ingredient was Calcium Citrate Malate, CAS 142606-53-9. The short answer was that it had not been verified, and that two different production lots had turned out to have meaningfully different calcium release profiles.